↓ Skip to main content

Dove Medical Press

Vipegitide: a folded peptidomimetic partial antagonist of α2β1 integrin with antiplatelet aggregation activity

Overview of attention for article published in Drug Design, Development and Therapy, January 2015
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
23 Mendeley
Title
Vipegitide: a folded peptidomimetic partial antagonist of α2β1 integrin with antiplatelet aggregation activity
Published in
Drug Design, Development and Therapy, January 2015
DOI 10.2147/dddt.s72844
Pubmed ID
Authors

Tatjana Momic, Jehoshua Katzhendler, Ela Shai, Efrat Noy, Hanoch Senderowitz, Johannes A Eble, Cezary Marcinkiewicz, David Varon, Philip Lazarovici

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 17%
Researcher 3 13%
Student > Ph. D. Student 3 13%
Student > Doctoral Student 2 9%
Student > Bachelor 1 4%
Other 3 13%
Unknown 7 30%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 13%
Agricultural and Biological Sciences 3 13%
Biochemistry, Genetics and Molecular Biology 3 13%
Medicine and Dentistry 3 13%
Computer Science 1 4%
Other 1 4%
Unknown 9 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2015.
All research outputs
#20,817,194
of 25,576,801 outputs
Outputs from Drug Design, Development and Therapy
#1,418
of 2,254 outputs
Outputs of similar age
#267,756
of 360,623 outputs
Outputs of similar age from Drug Design, Development and Therapy
#38
of 57 outputs
Altmetric has tracked 25,576,801 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,254 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,623 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.